Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Schrödinger today announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…
Enrollment Completed for ORION-1 Phase 2b Glaucoma Trial with Data Expected in Q4 2019 Enrollment Near Completion for MIRA-1 Phase…
First regulatory approval of NERLYNX in Latin America. NERLYNX is the first approved therapy to reduce the risk of invasive…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics,…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$SYBX—Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living…
BOSTON–(BUSINESS WIRE)–#biomarkers–Invicro LLC, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for…
DUBLIN–(BUSINESS WIRE)–The “Global Cephalosporin Drugs Market (2019-2025)” report has been added to ResearchAndMarkets.com’s offering. The Global Cephalosporin Drugs Market size…
The award-winning diagnostic clinical decision support system is designed to improve patient safety and educate specialists in the field of…